Overview

Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery

Status:
Not yet recruiting

Trial end date:
2021-04-01

Target enrollment:

Participant gender:

Summary

Our aim will be to evaluate the efficacy of perioperative Duloxetine in decreasing acute postoperative pain after laparoscopic colorectal cancer surgery and its role in reducing postoperative morphine requirements

Phase:

Phase 2

Details

Lead Sponsor:

Assiut University

Treatments:

Duloxetine Hydrochloride